Daniel Keizman

Research activity per year

Fingerprint

Dive into the research topics where Daniel Keizman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

47 Article
6 Review article
3 Comment/debate
1 Chapter
More
- 1 Short survey

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Gillessen, S., Turco, F., Davis, I. D., Efstathiou, J. A., Fizazi, K., James, N. D., Shore, N., Small, E., Smith, M., Sweeney, C. J., Tombal, B., Zilli, T., Agarwal, N., Antonarakis, E. S., Aparicio, A., Armstrong, A. J., Bastos, D. A., Attard, G., Axcrona, K. & Ayadi, M. & 101 others, Beltran, H., Bjartell, A., Blanchard, P., Bourlon, M. T., Briganti, A., Bulbul, M., Buttigliero, C., Caffo, O., Castellano, D., Castro, E., Cheng, H. H., Chi, K. N., Clarke, C. S., Clarke, N., de Bono, J. S., De Santis, M., Duran, I., Efstathiou, E., Ekeke, O. N., El Nahas, T. I. H., Emmett, L., Fanti, S., Fatiregun, O. A., Feng, F. Y., Fong, P. C. C., Fonteyne, V., Fossati, N., George, D. J., Gleave, M. E., Gravis, G., Halabi, S., Heinrich, D., Herrmann, K., Hofman, M. S., Hope, T. A., Horvath, L. G., Hussain, M. H. A., Jereczek-Fossa, B. A., Jones, R. J., Joshua, A. M., Kanesvaran, R., Keizman, D., Khauli, R. B., Kramer, G., Loeb, S., Mahal, B. A., Maluf, F. C., Mateo, J., Matheson, D., Matikainen, M. P., McDermott, R., McKay, R. R., Mehra, N., Merseburger, A. S., Morgans, A. K., Morris, M. J., Mrabti, H., Mukherji, D., Murphy, D. G., Murthy, V., Mutambirwa, S. B. A., Nguyen, P. L., Oh, W. K., Ost, P., O'Sullivan, J. M., Padhani, A. R., Parker, C., Poon, D. M. C., Pritchard, C. C., Rabah, D. M., Rathkopf, D., Reiter, R. E., Renard-Penna, R., Ryan, C. J., Saad, F., Sade, J. P., Sandhu, S., Sartor, O. A., Schaeffer, E., Scher, H. I., Sharifi, N., Skoneczna, I. A., Soule, H. R., Spratt, D. E., Srinivas, S., Sternberg, C. N., Suzuki, H., Taplin, M. E., Thellenberg-Karlsson, C., Tilki, D., Türkeri, L. N., Uemura, H., Ürün, Y., Vale, C. L., Vapiwala, N., Walz, J., Yamoah, K., Ye, D., Yu, E. Y., Zapatero, A. & Omlin, A., Feb 2025, In: European Urology. 87, 2, p. 157-216 60 p.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial
Grünwald, V., McKay, R. R., Buchler, T., Eto, M., Park, S. H., Takagi, T., Zanetta, S., Keizman, D., Suárez, C., Négrier, S., Lee, J. L., Santini, D., Bedke, J., Staehler, M., Kollmannsberger, C., Choueiri, T. K., Motzer, R. J., Burgents, J. E., Xie, R. & Okpara, C. E. & 1 others, Powles, T., 1 Apr 2025, In: International Journal of Cancer. 156, 7, p. 1326-1335 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
Rouvinov, K., Levanon, E., Peer, A., Sarfaty, M., Sarid, D., Neiman, V., Grikshtas, E., Rosenbaum, E., Kushnir, I., Talmor, B., Friger, M., Zarbiv, Y., Gez, E., Dresler, H., Shalata, W., Meirovitz, A., Shrem, N. S., Yakobson, A., Mermershtain, W. & Keizman, D., 2023, In: Frontiers in Oncology. 13, 1151701.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study
Keizman, D., Frenkel, M., Peer, A., Rosenbaum, E., Sarid, D., Leibovitch, I., Mano, R., Yossepowitch, O., Wolf, I., Geva, R., Margel, D., Rouvinov, K., Stern, A., Dresler, H., Kushnir, I. & Eliaz, I., Aug 2023, In: Nutrients. 15, 16, 3533.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Staging Prostate Cancer with ⁶⁸Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
Kesler, M., Cohen, D., Levine, C., Sarid, D., Keizman, D., Yossepowitch, O. & Even-Sapir, E., 2023, In: Journal of Nuclear Medicine. 64, 7, p. 1030-1035 6 p.
Research output: Contribution to journal › Article › peer-review

Open Access

Daniel Keizman

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial

Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study

Staging Prostate Cancer with ⁶⁸Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?

Daniel Keizman

Fingerprint

Collaborations and top research areas from the last five years

Research output

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial

Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study

Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?

Staging Prostate Cancer with ⁶⁸Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?